SOPHIA WEI: Open Payments
NPI 1922847169 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,845 in 105 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $683 · 2025 $1,845
Food & beverage: $1,845
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $337 |
| PFIZER INC. | 17 | $233 |
| Novo Nordisk Inc | 11 | $209 |
| AstraZeneca Pharmaceuticals LP | 5 | $199 |
| Otsuka America Pharmaceutical, Inc. | 8 | $147 |
| Lilly USA, LLC | 4 | $102 |
| GlaxoSmithKline, LLC. | 5 | $97 |
| Lundbeck LLC | 5 | $92 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Exact Sciences Corporation | 3 | $67 |
Products named: NURTEC ODT, FARXIGA, REXULTI, VRAYLAR, QULIPTA, Ozempic, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across VA — which companies pay providers there.
